Results 41 to 50 of about 1,144,553 (381)
The Lancet Planetary Health, 2021 Background: Yellow fever is an arboviral haemorrhagic disease transmitted by mosquitoes in the tropical regions of Africa and South America. WHO estimates that there are 200 000 severe cases and 30 000 deaths worldwide annually. In Brazil, the wild cycle
André Luís Acosta, PhD +4 more
doaj +1 more source
The thermal stability of yellow fever vaccines
Memorias do Instituto Oswaldo Cruz, 1990 The assessment of yellow fever vaccine thermostability both in lyophilized form and after reconstitution were analyzed. Two commercial yellow fever vaccines were assayed for their thermal stability. Vaccines were exposed to test temperatures in the range
Ricardo Ishak, Colin R. Howard
doaj +1 more source
Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009. [PDF]
PLoS Neglected Tropical Diseases, 2014 Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano +8 more
doaj +1 more source
Viruses, 2020 Yellow fever (YF) is a re-emerging viral zoonosis caused by the Yellow Fever virus (YFV), affecting humans and non-human primates (NHP). YF is endemic in South America and Africa, being considered a burden for public health worldwide despite the ...
P. de Oliveira Figueiredo +16 more
semanticscholar +1 more source
Yellow fever epizootics in non-human primates, Southeast and Northeast Brazil (2017 and 2018)
Parasites & Vectors, 2020 Yellow fever (YF) is a severe, infectious, but non-communicable arboviral hemorrhagic disease. In the last decades, yellow fever virus (YFV) infections have been prevalent in endemic areas in Brazil, affecting human and non-human primate (NHP ...
M. A. Mares-Guia +16 more
semanticscholar +1 more source
Yellow fever in the diagnostics laboratory [PDF]
, 2018 Yellow fever (YF) remains a public health issue in endemic areas despite the availability of a safe and effective vaccine. In 2015-2016, urban outbreaks of YF were declared in Angola and the Democratic Republic of Congo, and a sylvatic outbreak has been ...
Centers for Disease Control and Prevention (CDC +5 more
core +5 more sources
Anamnestic immune response to dengue and decreased severity of yellow fever
Journal of Global Infectious Diseases, 2009 A protective immunity against yellow fever, from cross-reactive dengue antibodies, has been hypothesized as an explanation for the absence of yellow fever in Southern Asia where dengue immunity is almost universal.
Ricardo O Izurieta +7 more
doaj +1 more source
Descriptive Characterization of Suspected Yellow Fever Cases in Kano state, Nigeria, 2015-2018
Journal of Interventional Epidemiology and Public Health, 2021 Introduction: Yellow fever remains a serious public health problem globally with an estimated 200, 000 cases annually despite the availability of an effective vaccine for more than 70 years. Nigeria had an outbreak of Yellow fever in 2017 after more than
Usman Yahya Umar +4 more
doaj +1 more source
Scientific Reports, 2020 Yellow Fever (YF) is a severe disease caused by Yellow Fever Virus (YFV), endemic in some parts of Africa and America. In Brazil, YFV is maintained by a sylvatic transmission cycle involving non-human primates (NHP) and forest canopy-dwelling mosquitoes,
M. S. Cunha +17 more
semanticscholar +1 more source
Yellow fever disease : density equalizing mapping and gender analysis of international research output [PDF]
, 2013 Background: A number of scientific papers on yellow fever have been published but no broad scientometric analysis on the published research of yellow fever has been reported. The aim of the article based study was to provide an in-depth evaluation of the
Bundschuh, Matthias +3 more
core